SHE:300119 Revenue

Tianjin Ringpu Bio-Technology had revenue of 821.62M CNY in the quarter ending March 31, 2025, with 20.00% growth. This brings the company's revenue in the last twelve months to 3.21B, up 8.67% year-over-year. In the year 2024, Tianjin Ringpu Bio-Technology had annual revenue of 3.07B with 13.32% growth.

Revenue (ttm)

3.21B

Revenue Growth

+8.67%

P/S Ratio

2.79

Revenue / Employee

1.11M

Employees

2,900

Market Cap

8.94B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.07B	360.83M	13.32%
Dec 31, 2023	2.71B	624.85M	29.98%
Jan 1, 2023	2.08B	77.11M	3.84%
Jan 1, 2022	2.01B	6.73M	0.34%
Dec 31, 2020	2.00B	533.83M	36.40%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Sichuan Biokin Pharmaceutical	5.82B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings